Skip to content
Screener

Biogen BIIB Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Rogers Corporation logo
Rogers CorporationROG
$19.9M-0.5%
TG Therapeutics logo
TG TherapeuticsTGTX
$2.21M+9.1%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.55M+57.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$256K0.0%
Regenxbio logo
RegenxbioRGNX
$5.9M+214%

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$30.53B+61.0%
Enterprise value$36.8B+61.4%
P/E34.6×+22.2×
P/S+1.1×

Profitability

See full
Gross margin74%-1.4pp
Operating margin22.9%
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Biogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 6:36 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000875045-26-000075
Line itemAs of June 30, 2026As of December 31, 2025
Intangible assets, net13,516.49,178.5
Goodwill6,990.86,491.1
Deferred tax asset202.1292.5
Investments and other assets831.8750.6
Total assets$32,086.6$29,439.5
LIABILITIES AND EQUITY
Current liabilities:
Current portion of term loan$800.0

Item 1. Financial Statements (unaudited)

FAQ

What is Biogen's other non-current assets?
Biogen (BIIB) reported other non-current assets of $831.8M in Q2 2026.
How has Biogen's other non-current assets changed year-over-year?
Biogen's other non-current assets increased by 30.4% year-over-year, from $637.7M to $831.8M.
What is the long-term trend for Biogen's other non-current assets?
Over 5 years (2020 to 2025), Biogen's other non-current assets has grown at a -23.7% compound annual growth rate (CAGR), from $2.9B to $750.6M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Biogen's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude